查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829896

2025年全球连续血糖监测设备市场报告

Continuous Glucose Monitoring Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，连续血糖监测设备市场规模快速扩张，从2024年的84.1亿美元成长到2025年的97.9亿美元，复合年增长率达16.4%。这一历史性增长可归因于患者安全性和健康状况的改善、糖尿病管理设备需求的不断增长、连续血糖监测设备（CGM）使用量的不断增长、糖尿病患者数量的不断增加以及患者信心的不断增强。

预计未来几年，连续血糖监测设备市场规模将快速成长，到2029年将达到181.8亿美元，复合年增长率为16.7%。预测期内的成长归因于医疗保健支出的增加、认知度的提高、糖尿病患者数量的增加、糖尿病盛行率的上升以及连续血糖监测设备的普及。预测期内的主要趋势包括技术进步、连续血糖监测技术创新、併购、监管核准以及合作伙伴关係和协作。

持续血糖监测 (CGM) 设备透过将感测器置于皮下，即时追踪血糖值。这些设备提供持续数据、趋势洞察以及高血糖和低血糖警报，帮助您更有效地管理糖尿病。 CGM 设备减少了频繁扎手指的需要，并改善了血糖控制。

连续血糖监测设备的主要组件包括发射器、感测器和接收器。发射器负责将血糖浓度数据从感测器发送到接收器（或连接的监测设备）。它通常透过蓝牙或 4G 技术连接。连续血糖监测设备 (CGM) 被广泛人群（从儿童到成人）使用，用于管理妊娠糖尿病、1 型糖尿病和 2 型糖尿病等疾病。这些设备广泛应用于各种环境，包括医院、居家照护机构和其他医疗保健机构。

2025年春季美国关税大幅上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供持续血糖监测设备市场统计数据，例如全球市场规模、区域份额、持续血糖监测设备市场份额的竞争对手、详细的持续血糖监测设备细分市场、市场趋势以及持续血糖监测设备行业的商机，为您提供在持续血糖监测设备行业取得成功所需的数据。本持续血糖监测设备市场研究报告提供了您所需的所有信息，并详细分析了该行业的现状和未来情况。

未来五年的预测成长率为16.7%，较我们先前对该市场的预测略有下降0.2%。下降的主要原因是美国与其他国家之间的关税影响。美国可能会直接感受到这种影响，例如对来自瑞士和韩国等主要地区的生物相容性黏合剂和微型电化学感测器征收关税，这可能导致设备短缺，并增加需要持续监测的糖尿病患者的医疗费用。此外，这种影响还将透过互惠关税以及不断升级的贸易紧张局势和限制对全球经济和贸易的负面影响，在更广泛的范围内显现。

糖尿病盛行率的上升预计将推动连续血糖监测设备市场的扩张。糖尿病是由于胰岛素分泌不足或胰岛素抗性导致身体无法正常调节血糖值的疾病。糖尿病盛行率上升的主要原因包括不良饮食、久坐不动的生活方式、肥胖、老化和遗传易感性。连续血糖监测 (CGM) 设备透过提供即时血糖值数据来协助糖尿病管理，从而能够及时调整治疗方案并改变生活方式。例如，英国政府健康改善与差异办公室于 2024 年 3 月报告称，在 2022 年 3 月至 2023 年 3 月期间，接受所有八项推荐护理程序的 1 型糖尿病患者比例增加了 22%，2 型糖尿病患者比例增加了 21%。此外，达到糖化血红素 (HbA1c) 目标的患者比例达到 37.9%，创下国家糖尿病审核(NDA) 记录的最高水准。因此，糖尿病盛行率的上升极大地促进了连续血糖监测设备市场的成长。

连续血糖监测设备市场的主要企业正专注于开发创新技术，例如非处方连续血糖监测仪，以提高个人管理血糖值的可及性、准确性和可用性。非处方 CGM 设备允许使用者无需处方笺即可持续监测血糖值。例如，2024 年 9 月，美国医疗设备公司雅培实验室推出了 Lingo 连续血糖监测系统。该设备为用户提供即时血糖数据，提供全天连续监测和即时回馈血糖值。它采用时尚的设计和易​​于阅读的显示屏，可与行动应用程式整合以追踪趋势和接收警报。

2023年9月，美国医疗设备製造商雅培实验室（Abbott Laboratories）收购了Bigfoot Biomedical，具体金额未揭露。此次收购将使雅培能够将Bigfoot Biomedical的智慧胰岛素管理系统与FreeStyle Libre技术结合，从而增强其糖尿病护理产品线。 Bigfoot Biomedical是一家总部位于美国的医疗科技公司，专注于提供与持续血糖监测(CGM)设备整合的解决方案。

持续血糖监测 (CGM) 设备的收益包括提供即时血糖监测、数据共用、趋势分析以及高低血糖警报等服务的营业单位所获得的收入。市场价值包括服务供应商销售的或包含在其服务产品中的相关产品的价值。持续血糖监测 (CGM) 设备市场还包括 Dexcom、FreeStyle Libre、 Medtronic和 Eversense 等产品的销售。该市场的价值是“出厂价”，即产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场中的产品价值还包括产品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球连续血糖监测设备：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球连续血糖监测设备市场：成长率分析
  • 全球连续血糖监测设备市场表现：规模与成长，2019-2024
  • 全球连续血糖监测设备市场预测：规模与成长，2024-2029年，2034年
  • 全球连续血糖监测设备：总目标市场（TAM）

第六章 市场细分

  • 全球连续血糖监测设备市场（按组件、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 发送器
  • 感应器
  • 接收器
  • 全球连续血糖监测设备市场：按连接性、性别、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • Bluetooth
  • 4G
  • 全球连续血糖监测设备市场规模、表现及预测（2019-2024、2024-2029、2034）
  • 儿科族群
  • 成年人口
  • 全球连续血糖监测设备市场应用、效能及预测（2019-2024、2024-2029、2034）
  • 妊娠糖尿病
  • 2型糖尿病
  • 1型糖尿病
  • 全球连续血糖监测设备市场（按最终用途、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 居家照护环境
  • 其他最终用户
  • 全球连续血糖监测设备市场：发送器细分（按类型）、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 蓝牙发射器
  • 发送器
  • 综合发射和接收系统
  • 全球连续血糖监测设备市场：按感测器类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 基于酵素的传感器
  • 电化学感测器
  • 非侵入式感测器
  • 全球连续血糖监测设备市场：接收器（按类型）细分、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 行动装置整合（智慧型手机接收器）
  • 独立接收器
  • 云端基础的资料同步接收器

第七章 区域和国家分析

  • 全球连续血糖监测设备市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球连续血糖监测设备市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 连续血糖监测设备市场：竞争格局
  • 连续血糖监测设备市场：公司简介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Public Limited Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Novo Nordisk A/S
  • Becton Dickinson and Company
  • A. Menarini Diagnostics Srl
  • Dexcom Inc.
  • Bionime Corporation
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings AG
  • Tandem Diabetes Care Inc.
  • i-Sens Inc.
  • Senseonics Holdings Inc.
  • Medtrum Technologies Inc.
  • Biolinq Inc.
  • GlySens Incorporated
  • Glucotrack Inc.
  • Nemaura Medical Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年连续血糖监测设备市场：提供新机会的国家
  • 2029年连续血糖监测设备市场：细分市场带来新机会
  • 2029年连续血糖监测设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r33663u

Continuous glucose monitoring (CGM) devices are used to track blood sugar levels in real time by placing a sensor under the skin. These devices offer continuous data, trend insights, and alerts for both high and low blood sugar levels, which helps manage diabetes more effectively. CGM devices reduce the need for frequent finger pricks and improve glucose control.

The primary components of continuous glucose monitoring devices include transmitters, sensors, and receivers. Transmitters are the components that transmit glucose level data from the sensor to the receiver or connected device for monitoring. They typically connect via Bluetooth or 4G technology. CGM devices are used across various demographics, including both children and adults, for managing conditions such as gestational diabetes, type-1 diabetes, and type-2 diabetes. These devices are utilized in a range of settings, including hospitals, homecare environments, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The continuous glucose monitoring devices market research report is one of a series of new reports from The Business Research Company that provides continuous glucose monitoring devices market statistics, including the continuous glucose monitoring devices industry global market size, regional shares, competitors with the continuous glucose monitoring devices market share, detailed continuous glucose monitoring devices market segments, market trends, and opportunities, and any further data you may need to thrive in the continuous glucose monitoring devices industry. This continuous glucose monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The continuous glucose monitoring devices market size has grown rapidly in recent years. It will grow from $8.41 billion in 2024 to $9.79 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to increased patient safety and improved health outcomes, increased demand for diabetes management devices, increased the use of CGM devices, a rise in the number of diabetes patients, and increased patient trust.

The continuous glucose monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $18.18 billion in 2029 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to increasing healthcare spending, increasing awareness, increasing number of diabetes cases, increasing prevalence of diabetes, and rising popularity of continuous glucose monitoring devices. Major trends in the forecast period include technological advancements, innovations in CGM technology, mergers and acquisitions, regulatory approvals, and partnerships and collaborations.

The forecast of 16.7% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on biocompatible adhesives and miniaturized electrochemical sensors, sourced from key regions such as Switzerland and South Korea, which could lead to device shortages and increased expenses for diabetic patients requiring constant monitoring.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of diabetes is expected to drive the expansion of the continuous glucose monitoring devices market. Diabetes is a condition where the body cannot properly regulate blood sugar levels, either due to insufficient insulin production or insulin resistance. The increasing rates of diabetes are primarily attributed to factors such as poor diets, sedentary lifestyles, obesity, aging populations, and genetic predispositions. Continuous glucose monitoring (CGM) devices aid in managing diabetes by providing real-time data on blood glucose levels, enabling timely treatment adjustments and lifestyle changes. For example, in March 2024, the Office for Health Improvement & Disparities, a UK-based government department, reported that between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes rose by 22%, while for type 2 diabetes, it increased by 21%. Additionally, the percentage of patients achieving target HbA1c levels reached 37.9%, the highest ever recorded in the National Diabetes Audit (NDA). As a result, the rising prevalence of diabetes is significantly contributing to the growth of the continuous glucose monitoring devices market.

Leading companies in the continuous glucose monitoring devices market are focused on developing innovative technologies, such as over-the-counter continuous glucose monitors, to improve accessibility, accuracy, and usability for individuals managing blood glucose levels. An over-the-counter CGM device allows users to continuously monitor their blood glucose levels without the need for a prescription. For instance, in September 2024, Abbott Laboratories, a US-based medical device company, launched the Lingo continuous glucose monitoring system. This device provides users with real-time glucose data, offering continuous monitoring and instant feedback on blood sugar levels throughout the day. It features a sleek design with easy-to-read displays and integrates with mobile apps for tracking trends and receiving alerts.

In September 2023, Abbott Laboratories, a US-based medical device company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. This acquisition allows Abbott to enhance its diabetes care offerings by combining Bigfoot Biomedical's smart insulin management systems with its Freestyle Libre technology. Bigfoot Biomedical, a US-based medical technology company, specializes in solutions that integrate with continuous glucose monitoring (CGM) devices.

Major players in the continuous glucose monitoring devices market are Johnson & Johnson, F. Hoffmann-La Roche AG, Sanofi S.A., Abbott Laboratories, Medtronic Public Limited Company, Novo Nordisk A/S, Becton Dickinson and Company, A. Menarini Diagnostics S.r.l., Dexcom Inc., Bionime Corporation, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Tandem Diabetes Care Inc., i-Sens Inc., Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., GlySens Incorporated, Glucotrack Inc., Nemaura Medical Inc.

North America was the largest region in the continuous glucose monitoring devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in continuous glucose monitoring devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the continuous glucose monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The continuous glucose monitoring (CGM) devices include revenues earned by entities by providing services such as real-time glucose monitoring, data sharing, trend analysis, and high or low alerts. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitoring (CGM) devices market also consists of sales of products including dexcom, freestyle libre, medtronic, and eversense. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Glucose Monitoring Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous glucose monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous glucose monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The continuous glucose monitoring devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Transmitters; Sensors; Receivers
  • 2) By Connectivity: Bluetooth; 4G
  • 3) By Demography: Child Population; Adult Population
  • 4) By Application: Gestational Diabetes; Type-2 Diabetes; Type-1 Diabetes
  • 5) By End-Use: Hospitals; Homecare Settings; Other End Users
  • Subsegments:
  • 1) By Transmitters: Bluetooth-Enabled Transmitters; Wireless Transmitters; Integrated Transmitter-Receiver Systems
  • 2) By Sensors: Enzyme-Based Sensors; Electrochemical Sensors; Non-Invasive Sensors
  • 3) By Receivers: Mobile Device Integration (Smartphone Receivers); Standalone Receivers; Cloud-Based Data Sync Receivers
  • Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche AG; Sanofi S.A.; Abbott Laboratories; Medtronic Public Limited Company; Novo Nordisk A/S; Becton Dickinson and Company; A. Menarini Diagnostics S.r.l.; Dexcom Inc.; Bionime Corporation; Insulet Corporation; Ascensia Diabetes Care Holdings AG; Tandem Diabetes Care Inc.; i-Sens Inc.; Senseonics Holdings Inc.; Medtrum Technologies Inc.; Biolinq Inc.; GlySens Incorporated; Glucotrack Inc.; Nemaura Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Continuous Glucose Monitoring Devices Market Characteristics

3. Continuous Glucose Monitoring Devices Market Trends And Strategies

4. Continuous Glucose Monitoring Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Continuous Glucose Monitoring Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Continuous Glucose Monitoring Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Continuous Glucose Monitoring Devices Market Growth Rate Analysis
  • 5.4. Global Continuous Glucose Monitoring Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Continuous Glucose Monitoring Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Continuous Glucose Monitoring Devices Total Addressable Market (TAM)

6. Continuous Glucose Monitoring Devices Market Segmentation

  • 6.1. Global Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transmitters
  • Sensors
  • Receivers
  • 6.2. Global Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bluetooth
  • 4G
  • 6.3. Global Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Child Population
  • Adult Population
  • 6.4. Global Continuous Glucose Monitoring Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gestational Diabetes
  • Type-2 Diabetes
  • Type-1 Diabetes
  • 6.5. Global Continuous Glucose Monitoring Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Homecare Settings
  • Other End Users
  • 6.6. Global Continuous Glucose Monitoring Devices Market, Sub-Segmentation Of Transmitters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bluetooth-Enabled Transmitters
  • Wireless Transmitters
  • Integrated Transmitter-Receiver Systems
  • 6.7. Global Continuous Glucose Monitoring Devices Market, Sub-Segmentation Of Sensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Based Sensors
  • Electrochemical Sensors
  • Non-Invasive Sensors
  • 6.8. Global Continuous Glucose Monitoring Devices Market, Sub-Segmentation Of Receivers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mobile Device Integration (Smartphone Receivers)
  • Standalone Receivers
  • Cloud-Based Data Sync Receivers

7. Continuous Glucose Monitoring Devices Market Regional And Country Analysis

  • 7.1. Global Continuous Glucose Monitoring Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Continuous Glucose Monitoring Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Continuous Glucose Monitoring Devices Market

  • 8.1. Asia-Pacific Continuous Glucose Monitoring Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Continuous Glucose Monitoring Devices Market

  • 9.1. China Continuous Glucose Monitoring Devices Market Overview
  • 9.2. China Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Continuous Glucose Monitoring Devices Market

  • 10.1. India Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Continuous Glucose Monitoring Devices Market

  • 11.1. Japan Continuous Glucose Monitoring Devices Market Overview
  • 11.2. Japan Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Continuous Glucose Monitoring Devices Market

  • 12.1. Australia Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Continuous Glucose Monitoring Devices Market

  • 13.1. Indonesia Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Continuous Glucose Monitoring Devices Market

  • 14.1. South Korea Continuous Glucose Monitoring Devices Market Overview
  • 14.2. South Korea Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Continuous Glucose Monitoring Devices Market

  • 15.1. Western Europe Continuous Glucose Monitoring Devices Market Overview
  • 15.2. Western Europe Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Continuous Glucose Monitoring Devices Market

  • 16.1. UK Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Continuous Glucose Monitoring Devices Market

  • 17.1. Germany Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Continuous Glucose Monitoring Devices Market

  • 18.1. France Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Continuous Glucose Monitoring Devices Market

  • 19.1. Italy Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Continuous Glucose Monitoring Devices Market

  • 20.1. Spain Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Continuous Glucose Monitoring Devices Market

  • 21.1. Eastern Europe Continuous Glucose Monitoring Devices Market Overview
  • 21.2. Eastern Europe Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Continuous Glucose Monitoring Devices Market

  • 22.1. Russia Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Continuous Glucose Monitoring Devices Market

  • 23.1. North America Continuous Glucose Monitoring Devices Market Overview
  • 23.2. North America Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Continuous Glucose Monitoring Devices Market

  • 24.1. USA Continuous Glucose Monitoring Devices Market Overview
  • 24.2. USA Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Continuous Glucose Monitoring Devices Market

  • 25.1. Canada Continuous Glucose Monitoring Devices Market Overview
  • 25.2. Canada Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Continuous Glucose Monitoring Devices Market

  • 26.1. South America Continuous Glucose Monitoring Devices Market Overview
  • 26.2. South America Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Continuous Glucose Monitoring Devices Market

  • 27.1. Brazil Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Continuous Glucose Monitoring Devices Market

  • 28.1. Middle East Continuous Glucose Monitoring Devices Market Overview
  • 28.2. Middle East Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Continuous Glucose Monitoring Devices Market

  • 29.1. Africa Continuous Glucose Monitoring Devices Market Overview
  • 29.2. Africa Continuous Glucose Monitoring Devices Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Continuous Glucose Monitoring Devices Market, Segmentation By Connectivity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Continuous Glucose Monitoring Devices Market, Segmentation By Demography, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Continuous Glucose Monitoring Devices Market Competitive Landscape And Company Profiles

  • 30.1. Continuous Glucose Monitoring Devices Market Competitive Landscape
  • 30.2. Continuous Glucose Monitoring Devices Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medtronic Public Limited Company Overview, Products and Services, Strategy and Financial Analysis

31. Continuous Glucose Monitoring Devices Market Other Major And Innovative Companies

  • 31.1. Novo Nordisk A/S
  • 31.2. Becton Dickinson and Company
  • 31.3. A. Menarini Diagnostics S.r.l.
  • 31.4. Dexcom Inc.
  • 31.5. Bionime Corporation
  • 31.6. Insulet Corporation
  • 31.7. Ascensia Diabetes Care Holdings AG
  • 31.8. Tandem Diabetes Care Inc.
  • 31.9. i-Sens Inc.
  • 31.10. Senseonics Holdings Inc.
  • 31.11. Medtrum Technologies Inc.
  • 31.12. Biolinq Inc.
  • 31.13. GlySens Incorporated
  • 31.14. Glucotrack Inc.
  • 31.15. Nemaura Medical Inc.

32. Global Continuous Glucose Monitoring Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Continuous Glucose Monitoring Devices Market

34. Recent Developments In The Continuous Glucose Monitoring Devices Market

35. Continuous Glucose Monitoring Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Continuous Glucose Monitoring Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Continuous Glucose Monitoring Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Continuous Glucose Monitoring Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer